公开(公告)号：US20160257721A1

公开(公告)日：2016-09-08

申请号：US14429803

申请日：2014-09-24

Applicant: UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION

Inventor： Andre LIEBER ,  Hongjie WANG

IPC: C07K14/005 ,  C12N7/00 ,  C12N5/077 ,  C07K7/06 ,  A61K47/42

CPC classification number: C07K14/005 ,  A61K38/00 ,  A61K47/42 ,  C07K7/06 ,  C07K2319/74 ,  C12N5/0652 ,  C12N7/00 ,  C12N15/10 ,  C12N15/86 ,  C12N2501/998 ,  C12N2506/00 ,  C12N2710/10022 ,  C12N2710/10033 ,  C12N2710/10321 ,  C12N2710/10322 ,  C12N2710/10333 ,  G01N33/94 ,  G01N2500/02 ,  G01N2500/20

Abstract: The present invention provides recombinant adenoviral compositions and methods for their use in treating disorders associated with epithelial tissues.

公开(公告)号：US20170247419A1

公开(公告)日：2017-08-31

申请号：US15593578

申请日：2017-05-12

Applicant: UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION

Inventor： Andre LIEBER ,  Hongjie WANG

IPC: C07K14/005 ,  G01N33/94 ,  C12N5/077 ,  C12N7/00 ,  A61K47/42

CPC classification number: C07K14/005 ,  A61K38/00 ,  A61K47/42 ,  C07K7/06 ,  C07K2319/74 ,  C12N5/0652 ,  C12N7/00 ,  C12N15/10 ,  C12N15/86 ,  C12N2501/998 ,  C12N2506/00 ,  C12N2710/10022 ,  C12N2710/10033 ,  C12N2710/10321 ,  C12N2710/10322 ,  C12N2710/10333 ,  G01N33/94 ,  G01N2500/02 ,  G01N2500/20

Abstract: The present invention provides recombinant adenoviral compositions and methods for their use in treating disorders associated with epithelial tissues.

公开(公告)号：US20240083953A1

公开(公告)日：2024-03-14

申请号：US18475950

申请日：2023-09-27

Applicant: UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION

Inventor： Andre LIEBER ,  Hongjie WANG

IPC: C07K14/005 ,  A61K47/42 ,  C07K7/06 ,  C12N5/077 ,  C12N7/00 ,  C12N15/10 ,  C12N15/86 ,  G01N33/94

CPC classification number: C07K14/005 ,  A61K47/42 ,  C07K7/06 ,  C12N5/0652 ,  C12N7/00 ,  C12N15/10 ,  C12N15/86 ,  G01N33/94 ,  A61K38/00 ,  C12N2710/10321 ,  C12N2710/10322

Abstract: Disclosed are recombinant adenoviral compositions and methods for their use in treating disorders associated with epithelial tissues.

公开(公告)号：US20200277336A1

公开(公告)日：2020-09-03

申请号：US16806617

申请日：2020-03-02

Applicant: UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION

Inventor： Andre LIEBER ,  Hongjie WANG

IPC: C07K14/005 ,  C12N15/10 ,  C12N15/86 ,  A61K47/42 ,  C07K7/06 ,  C12N5/077 ,  C12N7/00 ,  G01N33/94

Abstract: The present invention provides recombinant adenoviral compositions and methods for their use in treating disorders associated with epithelial tissues.

公开(公告)号：US20190092819A1

公开(公告)日：2019-03-28

申请号：US16206448

申请日：2018-11-30

Applicant: UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION

Inventor： Andre LIEBER ,  Hongjie WANG

IPC: C07K14/005 ,  C12N7/00 ,  G01N33/94 ,  C12N5/077 ,  A61K47/42 ,  C12N15/10 ,  C07K7/06 ,  C12N15/86 ,  A61K38/00

Abstract: The present invention provides recombinant adenoviral compositions and methods for their use in treating disorders associated with epithelial tissues.

公开(公告)号：US20220127308A1

公开(公告)日：2022-04-28

申请号：US17559391

申请日：2021-12-22

Applicant: UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION

Inventor： Andre LIEBER ,  Hongjie WANG

IPC: C07K14/005 ,  C12N15/10 ,  C12N15/86 ,  A61K47/42 ,  C07K7/06 ,  C12N5/077 ,  C12N7/00 ,  G01N33/94

Abstract: The present invention provides recombinant adenoviral compositions and methods for their use in treating disorders associated with epithelial tissues.